Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8656671 | Atherosclerosis | 2018 | 22 Pages |
Abstract
Improvement in inflammation associated with treatment of RA, using either abatacept or adalimumab in the AMPLE study, was associated with improvement in HDL function and significant alterations in the HDL proteome, including proteins involved in the immune response, proteinase inhibition, and lipid metabolism.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
C. Charles-Schoeman, G.B. Gugiu, H. Ge, A. Shahbazian, Y.Y. Lee, X. Wang, D.E. Furst, V.K. Ranganath, M. Maldonado, Terry Lee, S.T. Reddy,